Fair Access to Clinical Trials Act

H.R. 3196, the Fair Access to Clinical Trials Act, would require the Department of Health and Human Services to create a comprehensive public database for all clinical trials involving drugs, medical devices, and biological products. This registry would provide citizens with easy access to information regarding the purpose, methodology, and final results of medical studies through a centralized website. By mandating the disclosure of both positive and negative trial outcomes, the bill aims to increase transparency in medical research and help patients and healthcare providers make more informed decisions about treatments.